CME Group Inc. $CME Shares Acquired by Mirae Asset Global Investments Co. Ltd.

Mirae Asset Global Investments Co. Ltd. boosted its stake in CME Group Inc. (NASDAQ:CME) by 7.0% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 87,179 shares of the financial services provider’s stock after acquiring an additional 5,733 shares during the period. Mirae Asset Global Investments Co. Ltd.’s holdings in CME Group were worth $23,555,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Amundi grew its stake in shares of CME Group by 24.0% during the 2nd quarter. Amundi now owns 1,987,347 shares of the financial services provider’s stock worth $548,150,000 after purchasing an additional 385,225 shares during the period. Alley Investment Management Company LLC boosted its holdings in CME Group by 86.0% during the third quarter. Alley Investment Management Company LLC now owns 29,223 shares of the financial services provider’s stock worth $7,896,000 after buying an additional 13,512 shares in the last quarter. Elevate Capital Advisors LLC boosted its holdings in CME Group by 85.2% during the third quarter. Elevate Capital Advisors LLC now owns 8,519 shares of the financial services provider’s stock worth $2,302,000 after buying an additional 3,919 shares in the last quarter. Victory Financial Group LLC grew its position in CME Group by 310.2% during the second quarter. Victory Financial Group LLC now owns 3,044 shares of the financial services provider’s stock worth $839,000 after buying an additional 2,302 shares during the period. Finally, Chicago Capital LLC increased its holdings in CME Group by 583.8% in the third quarter. Chicago Capital LLC now owns 13,327 shares of the financial services provider’s stock valued at $3,601,000 after buying an additional 11,378 shares in the last quarter. 87.75% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities research analysts have recently commented on CME shares. UBS Group reissued a “neutral” rating on shares of CME Group in a research note on Tuesday, January 6th. Morgan Stanley decreased their target price on CME Group from $320.00 to $319.00 and set an “overweight” rating on the stock in a research report on Thursday, January 15th. Piper Sandler lifted their target price on shares of CME Group from $296.00 to $313.00 and gave the stock an “overweight” rating in a research report on Thursday, November 13th. The Goldman Sachs Group lowered their price target on shares of CME Group from $265.00 to $264.00 and set a “sell” rating on the stock in a research report on Wednesday, January 14th. Finally, JPMorgan Chase & Co. raised their price objective on shares of CME Group from $256.00 to $262.00 and gave the stock an “underweight” rating in a research note on Thursday, January 22nd. Nine investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $292.18.

CME Group Stock Performance

Shares of CME opened at $289.83 on Friday. CME Group Inc. has a 1 year low of $233.12 and a 1 year high of $291.76. The company’s 50 day simple moving average is $274.93 and its 200 day simple moving average is $272.27. The company has a market capitalization of $104.51 billion, a price-to-earnings ratio of 28.08, a PEG ratio of 3.22 and a beta of 0.27. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02.

CME Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, December 30th. Shareholders of record on Friday, December 12th were paid a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a yield of 1.7%. The ex-dividend date of this dividend was Friday, December 12th. CME Group’s dividend payout ratio (DPR) is presently 48.45%.

More CME Group News

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: Analysts and data services expect a likely earnings beat ahead of CME’s upcoming release (market consensus/non‑GAAP EPS previews and previews noting the company’s revenue mix). Positive guidance/expectations ahead of the report are supporting the stock. Will CME Group (CME) beat quarterly earnings? CME Group (CME) Earnings Expected to Grow
• Positive Sentiment: CME expanded crypto derivatives with options on its Bitcoin Friday futures, broadening products for institutional and retail-facing flows — potential to increase volumes and fee revenue as crypto activity grows. CME Group Expands Crypto Offerings With Options On Bitcoin Friday Futures
• Positive Sentiment: CME issued a self‑certification that could let FanDuel and DraftKings offer Super Bowl parlays on prediction markets using CME infrastructure — a new use case that could drive volume and broaden commercial relationships. FanDuel and DraftKings prediction markets could offer Super Bowl parlays, as CME issues self-certification
• Positive Sentiment: Reported short interest fell earlier in January (down ~15.6% to ~4.21M shares as of Jan 15), reducing potential downside pressure from short-covering and signaling less bearish positioning. (Data feed)
• Neutral Sentiment: CME signed a multiyear jersey-patch sponsorship with the Chicago White Sox — increases brand visibility in its hometown market but likely a modest near-term financial impact relative to core derivatives revenue. CME Group Named as First-Ever Chicago White Sox Jersey Patch Sponsor
• Neutral Sentiment: There is an anomalous/erroneous short‑interest entry showing zero shares for late‑January that appears to be a reporting error — investors should rely on the earlier, validated short‑interest update. (Data feed)

Insiders Place Their Bets

In related news, CEO Terrence A. Duffy sold 25,000 shares of the business’s stock in a transaction that occurred on Thursday, December 11th. The shares were sold at an average price of $269.55, for a total value of $6,738,750.00. Following the completion of the sale, the chief executive officer directly owned 65,804 shares in the company, valued at approximately $17,737,468.20. The trade was a 27.53% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Harold Eugene Jr. Ford sold 1,000 shares of the stock in a transaction that occurred on Monday, November 3rd. The stock was sold at an average price of $263.53, for a total transaction of $263,530.00. Following the transaction, the director directly owned 1,091 shares in the company, valued at approximately $287,511.23. This represents a 47.82% decrease in their position. The SEC filing for this sale provides additional information. 0.30% of the stock is owned by corporate insiders.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.